Funding for this research was provided by:
aging minds foundation
cure alzheimer's foundation
berry cox foundation
national institutes of health (RF1AG059689)
hans & ilse breuer foundation
Received: 3 September 2021
Accepted: 3 September 2021
First Online: 11 October 2021
: All animal maintenance and experiments adhered to the animal care and use protocols of the University of Texas Southwestern Medical Center. The autopsy brains used for this study were obtained in compliance with Ulm University ethics committee guidelines as well as German federal and state law governing human tissue usage.
: Not applicable.
: MID is co-developer of an anti-tau antibody currently in clinical trials (C2N 8E12 [NCT02494024]). The remaining authors declare that they have no competing interests.